Bringing It Home and Carrying It Forward
EMBARK Psychedelic Therapy for Depression April 23, 2024 DOI: 10.1093/9780197762622.003.0009 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Key points | Argues that psychedelic-assisted therapy should move from a treatment-focused approach toward a more integrated conceptualization and treatment process, and suggests psychedelics may be more suited to promoting overall well-being than simply reducing symptoms. Emphasizes the overlooked role of community support and outlines future directions for the EMBARK model in research and practice. |
Abstract
AbstractChapter 8 concludes the book with a reflection on the intense and meaningful journey of providing psychedelic-assisted therapy. It acknowledges the book’s aim to provide a comprehensive guide to practicing psychedelic therapy, rooted in the best available evidence and ethical considerations. The chapter points to future opportunities in the field, including a shift from a treatment-focused approach to a more integrated conceptualization and treatment process. It raises important questions about the best use of psychedelics in mental health care, suggesting that they may be more suited to promoting overall well-being than simply reducing symptoms. It also discusses the important but overlooked role of community support and explores the question of what collective changes would best support the integration of psychedelic therapy into our culture’s approach to healing. Future directions for EMBARK in psychedelic therapy research and practice are outlined. The chapter concludes by honoring the reader’s interest in psychedelic therapy.
Citations in the library
Cites 217
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
and 212 more in the library